JP2004517069A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517069A5
JP2004517069A5 JP2002543486A JP2002543486A JP2004517069A5 JP 2004517069 A5 JP2004517069 A5 JP 2004517069A5 JP 2002543486 A JP2002543486 A JP 2002543486A JP 2002543486 A JP2002543486 A JP 2002543486A JP 2004517069 A5 JP2004517069 A5 JP 2004517069A5
Authority
JP
Japan
Prior art keywords
alkyl
triazol
pharmaceutically acceptable
phenyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002543486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517069A (ja
Filing date
Publication date
Priority claimed from GBGB0027987.7A external-priority patent/GB0027987D0/en
Application filed filed Critical
Publication of JP2004517069A publication Critical patent/JP2004517069A/ja
Publication of JP2004517069A5 publication Critical patent/JP2004517069A5/ja
Withdrawn legal-status Critical Current

Links

JP2002543486A 2000-11-16 2001-11-15 Tgf阻害剤としてのピリジル置換トリアゾール類 Withdrawn JP2004517069A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027987.7A GB0027987D0 (en) 2000-11-16 2000-11-16 Compounds
PCT/GB2001/005036 WO2002040476A1 (en) 2000-11-16 2001-11-15 Pyridyl-substituted triazoles as tgf inhibitors

Publications (2)

Publication Number Publication Date
JP2004517069A JP2004517069A (ja) 2004-06-10
JP2004517069A5 true JP2004517069A5 (https=) 2005-12-22

Family

ID=9903300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002543486A Withdrawn JP2004517069A (ja) 2000-11-16 2001-11-15 Tgf阻害剤としてのピリジル置換トリアゾール類

Country Status (6)

Country Link
US (1) US20040152738A1 (https=)
EP (1) EP1335916A1 (https=)
JP (1) JP2004517069A (https=)
AU (1) AU2002214163A1 (https=)
GB (1) GB0027987D0 (https=)
WO (1) WO2002040476A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127430D0 (en) * 2001-11-15 2002-01-09 Smithkline Beecham Corp Compounds
GB0127433D0 (en) * 2001-11-15 2002-01-09 Smithkline Beecham Corp Compounds
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
GB0217783D0 (en) * 2002-07-31 2002-09-11 Glaxo Group Ltd Compounds
GB0217780D0 (en) * 2002-07-31 2002-09-11 Glaxo Group Ltd Compounds
GB0217786D0 (en) * 2002-07-31 2002-09-11 Glaxo Group Ltd Compounds
WO2004013135A1 (en) * 2002-07-31 2004-02-12 Smithkline Beecham Corporation 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
GB0217787D0 (en) * 2002-07-31 2002-09-11 Glaxo Group Ltd C ompounds
UA80295C2 (en) 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
PL375973A1 (en) * 2002-09-18 2005-12-12 Pfizer Products Inc. Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
CA2497971A1 (en) 2002-09-18 2004-04-01 Pfizer Products Inc. Triazole derivatives as transforming growth factor (tgf) inhibitors
MXPA05002332A (es) * 2002-09-18 2005-06-08 Pfizer Prod Inc Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf).
HRP20050247A2 (en) 2002-09-18 2005-10-31 Pfizer Products Inc. Pyrazole derivatives as transforming growth factor (tgf) inhibitors
JP4547271B2 (ja) * 2002-09-18 2010-09-22 ファイザー・プロダクツ・インク トランスフォーミング増殖因子(tgf)阻害剤としての新規イミダゾール化合物
CA2513086A1 (en) * 2002-12-19 2004-07-08 Scios Inc. Treatment of obesity and associated conditions with tgf-.beta. inhibitors
PA8595001A1 (es) 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
GB0313915D0 (en) * 2003-06-16 2003-07-23 Smithkline Beecham Corp Compounds
NZ549003A (en) * 2004-03-05 2009-07-31 Taisho Pharmaceutical Co Ltd Thiazole derivative as an ALK5 inhibitor
JP5149177B2 (ja) 2005-07-25 2013-02-20 シンタ ファーマシューティカルズ コーポレーション 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤
WO2007070866A2 (en) * 2005-12-16 2007-06-21 Alcon, Inc. Control of intraocular pressure using alk5 modulation agents
US8586581B2 (en) 2009-12-17 2013-11-19 Hoffmann-La Roche Inc Ethynyl compounds useful for treatment of CNS disorders
CA2874764C (en) 2012-05-30 2022-11-01 Cornell University Generation of functional and durable endothelial cells from human amniotic fluid-derived cells
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
RU2688665C2 (ru) 2014-04-22 2019-05-22 Университет Базель Новый способ получения производных триазина, пиримидина и пиридина
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
WO2022251359A1 (en) * 2021-05-26 2022-12-01 Theravance Biopharma R&D Ip, Llc Bicyclic inhibitors of alk5 and methods of use
US12240830B2 (en) * 2021-08-13 2025-03-04 Bisichem Co., Ltd. Fused ring heteroaryl compounds and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525201A (ja) * 1998-08-20 2003-08-26 スミスクライン・ビーチャム・コーポレイション 新規な置換トリアゾール化合物

Similar Documents

Publication Publication Date Title
JP2004517069A5 (https=)
RU2004117862A (ru) Фенилзамещенные триазолы и их применение в качестве селективных ингибиторов alk5 киназы
JP4073786B2 (ja) 高コンダクタンス型カルシウム感受性kチャネル開口薬
JP2020527560A5 (https=)
US20230346927A1 (en) COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS
JP2001526269A5 (https=)
JP2004531473A5 (https=)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
RU2011105151A (ru) Азольные соединения
RU2001102777A (ru) Оксазоло-, тиазоло- и селеназоло [4,5-с] -хинолин-4-амины и их аналоги
RU2008141511A (ru) Конденсированные гетероциклические соединения и их применение в качестве модуляторов mglur5
JP2009513700A5 (https=)
JP2006518333A5 (https=)
JP2019537594A5 (https=)
ES2342783T3 (es) Aril aciltioureas sustituidas y compuestos relacionados, inhibidores de la replicacion viral.
JP2009544742A5 (https=)
RU2002117450A (ru) Новые гетероциклические соединения и их соли и их применение в медицине
JP2010513304A5 (https=)
US11660301B2 (en) Combination of ATR kinase inhibitors with PARP inhibitors
JP2011503230A5 (https=)
CA2564442A1 (en) 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
JP2020520354A5 (https=)
JP2005537323A5 (https=)
WO2018153971A1 (en) Combination of atr kinase inhibitors
JP2018525371A5 (https=)